ArticleAmerican journal of cancer research2022

Claudin 19 inhibits the malignant potential of breast cancer cells by modulating extracellular matrix-associated UBE2C/Wnt signaling.

Jingxiu Xu et al.PubMed ↗Full text ↗

No numbers read from the abstract.